For chronic pain sufferers an app may be just the tool they need to manage their pain. In a UHN-led study that used the app "Manage My Pain" enrolled patients saw clinically significant reductions in key areas that drive increased medical needs, potential abuse of prescription opioids and of course, pain.
The drug buprenorphine is an effective treatment for opioid use disorder, but many who misuse opioids also take benzodiazepines -- drugs that treat anxiety and similar conditions. Many treatment centers hesitate to treat patients addicted to opioids who also take benzodiazepines. Researchers at Washington University School of Medicine in St. Louis studied overdose risk in people taking buprenorphine and found that the drug lowered risk, even in people taking benzodiazepines.
In an analysis of nationwide data from the Veterans Health Administration, approximately one-quarter of individuals with kidney stones had a diagnosis of osteoporosis or bone fracture around the time of their kidney stone diagnosis. The findings are published in the Journal of Bone and Mineral Research.
A UOC study shows that factors such as job insecurity, worrying about the future and fear of contagion may have a negative impact on people living with pain
A large proportion of the benefit that a person gets from taking a real drug or receiving a treatment to alleviate pain is due to an individual's mindset, not to the drug itself. Understanding the neural mechanisms driving this placebo effect has been a longstanding question. A meta-analysis published in Nature Communications finds that placebo treatments to reduce pain, known as placebo analgesia, reduce pain-related activity in multiple areas of the brain.
Initial management with inhaled methoxyflurane in the emergency department did not achieve the prespecified substantial reduction in pain, but was associated with clinically significant lower pain scores compared to standard therapy.
A new review published by Wiley in the journal Advanced Genetics analyzes disparities in experience and treatment of sickle cell disease.
Using cannabis for relief from migraine headache may be associated with developing "rebound" headache, or medication overuse headache, which occurs when pain medication is overused by patients who have an underlying primary headache disorder such as migraine, according to a preliminary study released today March 1, 2021, that will be presented at the American Academy of Neurology's 73rd Annual Meeting being held virtually April 17 to 22, 2021.
A prescribing guideline tailored to patients' specific needs reduced the number of opioid pills prescribed after major surgery.
Results of a world-first Canadian pilot study on patients treated with gene therapy for Fabry disease show that the treatment is working and safe.